TABLE 4:
Therapeutic area | Percentage mentioned* | Percentage critically important antibiotics (CIAs) v percentage other antibiotics used for treatment | Frequency of use of the different classes of antibiotics (top 5) |
---|---|---|---|
Respiratory disease | 31% |
CIAs: 12% Non CIAs: 88% |
Tetracyclines 47%, Penicillins 21%, Macrolides 10%, Potentiated sulphonamides 8%, Phenicol 5% |
Diarrhoea including Colibacillosis Dysentery |
31% (8%) (4%) |
CIAs: 34% Non-CIAs: 66% |
Polymyxin 30%, Macrolides 22%, (Fluoro)quinolones 12%, Potentiated sulphonamides 11%, Pleuromutilin 7% |
Streptococcus suis infection including Arthritis Lameness Meningitis |
17% (4%) (2%) (1%) |
CIAs: 5% Non-CIAs: 95% |
Penicillins 81%, Lincosamide 5%, Potentiated sulphonamides 4%, 3rd and 4th generation Cephalosporins 3%, Aminoglycosides 4% |
Postpartum dysgalactia syndrome (PPDS) | 12% |
CIAs: 31% Non-CIAs: 69% |
Penicillins 41%, (Fluoro)quinolones 21%, Potentiated sulphonamides 21%, 3rd and 4th generation Cephalosporins 7% Macrolides 3% |
Others | 9% |
CIAs: 14% Non-CIAs: 86% |
Penicillins 56%, Aminoglycosides 12% Tetracyclines 12%, Macrolides 7%, (Fluoro)quinolones 5% |
*Percentages in brackets are part of the percentage mentioned of each therapeutic area.